Cyclerion Therapeutics

$2.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-2.22%) Today
+$0.02 (+0.76%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CYCN and other stocks, options, and ETFs commission-free!

About CYCN

Cyclerion Therapeutics, Inc. Common Stock, also called Cyclerion Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Read More Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA. The listed name for CYCN is Cyclerion Therapeutics, Inc. Common Stock.

Employees
94
Headquarters
Cambridge, Massachusetts
Founded
2018
Market Cap
89.55M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.71M
High Today
$2.72
Low Today
$2.61
Open Price
$2.70
Volume
491.46K
52 Week High
$14.77
52 Week Low
$1.69

Collections

CYCN Earnings

-$1.36
-$0.91
-$0.45
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, Pre-Market

You May Also Like